House looks to weaken Medicare negotiation

Stat News

29 February 2024 - Two proposals to weaken Medicare’s drug price negotiation program are getting a hearing before a House Energy & Commerce subcommittee today.

One bill, dubbed the ORPHAN Cures Act, would allow an orphan drug to avoid negotiation as long as it is approved exclusively for rare diseases. Currently, the law only exempts drugs that have a single orphan designation from the negotiation process.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Regulation , Medicare